Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Cash & Current Investments (2023 - 2025)

Historic Cash & Current Investments for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $498223.0.

  • Mangoceuticals' Cash & Current Investments rose 44837.76% to $498223.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $498223.0, marking a year-over-year increase of 44837.76%. This contributed to the annual value of $75595.0 for FY2024, which is 9000.0% down from last year.
  • According to the latest figures from Q3 2025, Mangoceuticals' Cash & Current Investments is $498223.0, which was up 44837.76% from $117961.0 recorded in Q2 2025.
  • Over the past 5 years, Mangoceuticals' Cash & Current Investments peaked at $2.9 million during Q2 2023, and registered a low of $15305.0 during Q1 2024.
  • For the 3-year period, Mangoceuticals' Cash & Current Investments averaged around $632180.9, with its median value being $304102.0 (2024).
  • In the last 5 years, Mangoceuticals' Cash & Current Investments crashed by 9265.38% in 2024 and then skyrocketed by 51050.64% in 2025.
  • Quarter analysis of 3 years shows Mangoceuticals' Cash & Current Investments stood at $755948.0 in 2023, then plummeted by 90.0% to $75595.0 in 2024, then soared by 559.07% to $498223.0 in 2025.
  • Its Cash & Current Investments stands at $498223.0 for Q3 2025, versus $117961.0 for Q2 2025 and $93438.0 for Q1 2025.